Press Release Summary:
Used for simultaneous screening of amphetamine, opiates, cocaine, PCP, methamphetamine, and THC drugs, OnSiteÃ‚Â® OraLabÃ‚Â® oral fluid drug testing device is used for pre-employment, random, reasonable suspicion, and post-accident testing, as well as for court-mandated compliance. Expresser and single tube design allow collection and storage of saliva for immediate screening and confirmation testing.
Original Press Release:
Varian, Inc. Launches New and Improved OnSiteÂ® OraLabÂ® Device
PALO ALTO, Calif., Aug. 2 / - Varian, Inc. (NASDAQ:VARI) today announced a new and improved version of the OnSiteÂ® OraLabÂ® oral fluid drug testing device. Featuring a proprietary detection methodology, the new OraLab is more accurate and achieves lower detection limits for parent-THC than previous devices. OraLab is an extension of Varian, Inc.'s drugs of abuse oral fluid testing product line that offers devices for both onsite and lab-based testing.
With fewer than half the steps required by other oral fluid tests, OraLab's "no mess" design is truly simple and easy to administer. Its testing process is 100% observable and eliminates the need for special facilities or gender-specific staffing, which makes specimen tampering less likely. The new OraLab's unique patent-pending expresser and single tube design allows collection and storage of sufficient saliva for both immediate screening and confirmation testing.
OraLab is used for pre-employment, random, reasonable suspicion, and post-accident testing, as well as for court-mandated compliance. OraLab simultaneously screens for six drugs - amphetamine, opiates, cocaine, PCP, methamphetamine, and THC. It is also available in a three-drug test panel for amphetamine, opiates, and cocaine.
"There continues to be growing interest in oral fluid testing because of the many benefits of oral fluid collection over urine collection. The new and improved OraLab not only offers our customers more sensitive and more accurate detection of parent-THC, it's also easier to use. With three easy steps - collect, test, and store - test results are ready in minutes," said Stephen Schultheis, Consumable Products Vice President and General Manager, Varian, Inc. "If a customer wants to detect "under the influence" drug use, oral fluid testing is the ideal choice."
Varian, Inc. offers a total solution for its customers' drug testing programs - from confirmation and adulteration testing (gas chromatography/mass spectrometry GC/MS and liquid chromatography/mass spectrometry LC/MS) to broad spectrum testing (TOXILABÂ®). OraLabÂ® products are complemented by Web-based operator training and certification programs, and 24-hour telephone technical support.
OraLab is available for shipment. For more product information, please visit www.varianinc.com/cgi-bin/nav?products/dat/oralab&cid=JIMJMOOLFM
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum components, laboratory consumable supplies, software, training, and support through its global distribution and support systems. Varian, Inc. employs approximately 3,700 people and operates manufacturing facilities in 14 locations in North America, Europe, and the Pacific Rim. Varian, Inc. had fiscal year 2005 sales of $773 million (excluding the divested Electronics Manufacturing segment), and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: www.varianinc.com.
For More Information,
Source: Varian, Inc.
Web site: www.varianinc.com/